Portal de Periódicos da CAPES

Pharmacogenetic Information in Clinical Guidelines: The European Perspective

2018; Wiley; Volume: 103; Issue: 5 Linguagem: Inglês

10.1002/cpt.1049

1532-6535

Jesse J. Swen, Marga Nijenhuis, Mandy van Rhenen, Nienke J. de Boer‐Veger, Anne‐Marie Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Ron H. N. van Schaik, Jan van der Weide, Bob Wilffert, Vera H.M. Deneer, Henk‐Jan Guchelaar,

Pharmaceutical studies and practices

Surveys among pharmacists and physicians show that these healthcare professionals have successfully adopted the concept of pharmacogenomics (PGx). 1‐3 In addition, patients are willing to consent to participate in PGx implementation studies. 4 However, the surveys also show that healthcare professionals do not frequently order or recommend a PGx test. 1,2 Among others, a frequently perceived hurdle for clinical uptake of PGx is the availability of guidelines translating PGx test results into clinical actions for individual patients. 5,6